Norma Lynn Fox

Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study

William Stohl, Andreas Schwarting, Masato Okada et al. · Arthritis & Rheumatology · 2017 · 417 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Phase I Pharmacokinetic and Biologic Correlative Study of Mapatumumab, a Fully Human Monoclonal Antibody With Agonist Activity to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor-1

Anthony W. Tolcher, Monica Mita, Neal J. Meropol et al. · Journal of Clinical Oncology · 2007 · 311 citations · Full text

Medicine, Oncology, Pharmacology +17

TNK-Tissue Plasminogen Activator in Acute Myocardial Infarction

Christopher P. Cannon, Carolyn H. McCabe, C. Michael Gibson et al. · Circulation · 1997 · 246 citations

Medicine, Cardiology, Pharmacology +9

Phase 1 and Pharmacokinetic Study of Lexatumumab in Patients with Advanced Cancers

Ruth Plummer, Gerhardt Attard, Simon Pacey et al. · Clinical Cancer Research · 2007 · 245 citations · Full text

Medicine, Oncology, Pharmacology +17

A Phase 1 Study of Mapatumumab (Fully Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies

Sebastién J. Hotte, Hal W. Hirte, Eric X. Chen et al. · Clinical Cancer Research · 2008 · 189 citations

Life Sciences, Oncology, Pharmacology +17